Hasta la próxima

Auto reproducción

Advanced or Recurrent Endometrial Cancer Clinical Trial

0 vistas • 07/09/23
Compartir
Empotrar
administrator
administrator
Suscriptores
0

The purpose of this clinical trial is to study the good and bad effects of adding the PD-1 inhibitor called pembrolizumab to standard treatment for advanced or recurrent endometrial cancer. http://www.bigtencrc.org

Mostrar más
0 Comentarios sort Ordenar por
Comentarios de Facebook

Hasta la próxima

Auto reproducción